Clinical Trials Browser

Phase 1 × Liver Neoplasms × Radiotherapy × Clear all

NCT02989870 2020-06-05

Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma

Phase 1 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT01618253 2013-09-05

Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinoma

Phase 1 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms